CARA - Cara Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CARA is currently covered by 5 analysts with an average price target of $3.86. This is a potential upside of $-1.46 (-27.44%) from yesterday's end of day stock price of $5.32.

Cara Therapeutic's activity chart (see below) currently has 17 price targets and 34 ratings on display. The stock rating distribution of CARA is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.75% with an average time for these price targets to be met of 338.42 days.

Highest price target for CARA is $10, Lowest price target is $10, average price target is $8.5.

Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 13-Jun-2024. First documented stock forecast 27-Feb-2014.

Currently out of the existing stock ratings of CARA, 15 are a BUY (75%), 5 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

$25

10 months 3 days ago
(13-Jun-2024)

4/4 (100%)

$-10.28 (-29.14%)

417

Hold

$10

$5.1 (104.08%)

$23

10 months 3 days ago
(13-Jun-2024)

3/4 (75%)

$4.68 (87.97%)

251

Hold

$3.6

10 months 3 days ago
(13-Jun-2024)

6/6 (100%)

$-5.52 (-60.53%)

204

Hold

$5

10 months 3 days ago
(13-Jun-2024)

11/11 (100%)

$-3.81 (-43.25%)

119

Hold

$12

$7.1 (144.90%)

$12

1 years 5 months 2 days ago
(14-Nov-2023)

3/3 (100%)

$-1.14 (-8.68%)

100

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CARA (Cara Therapeutic) average time for price targets to be met?

On average it took 338.42 days on average for the stock forecasts to be realized with a an average price target met ratio 83.75

Which analyst has the current highest performing score on CARA (Cara Therapeutic) with a proven track record?

ANNABEL SAMIMY

Which analyst has the most public recommendations on CARA (Cara Therapeutic)?

Annabel Samimy works at STIFEL and has 4 price targets and 8 ratings on CARA

Which analyst is the currently most bullish on CARA (Cara Therapeutic)?

Chris Howerton with highest potential upside - $35.38

Which analyst is the currently most reserved on CARA (Cara Therapeutic)?

Jason Gerberry with lowest potential downside - -$1.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?